Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry.
Utah Medical Products Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$89.00|
|52 Week High||US$77.80|
|52 Week Low||US$95.65|
|1 Month Change||3.13%|
|3 Month Change||4.76%|
|1 Year Change||9.12%|
|3 Year Change||-6.86%|
|5 Year Change||45.90%|
|Change since IPO||1,235.00%|
Recent News & Updates
Utah Medical Products (NASDAQ:UTMD) Has Affirmed Its Dividend Of US$0.28
The board of Utah Medical Products, Inc. ( NASDAQ:UTMD ) has announced that it will pay a dividend on the 5th of...
|UTMD||US Medical Equipment||US Market|
Return vs Industry: UTMD underperformed the US Medical Equipment industry which returned 34.6% over the past year.
Return vs Market: UTMD underperformed the US Market which returned 33.8% over the past year.
Stable Share Price: UTMD is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 2% a week.
Volatility Over Time: UTMD's weekly volatility (2%) has been stable over the past year.
About the Company
Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. It also provides GESCO umbilical vessel catheters; DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies.
Is Utah Medical Products undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: UTMD ($89) is trading below our estimate of fair value ($126.94)
Significantly Below Fair Value: UTMD is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: UTMD is good value based on its PE Ratio (25.4x) compared to the US Medical Equipment industry average (53.4x).
PE vs Market: UTMD is poor value based on its PE Ratio (25.4x) compared to the US market (17.8x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate UTMD's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: UTMD is good value based on its PB Ratio (3x) compared to the US Medical Equipment industry average (4.8x).
How is Utah Medical Products forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Utah Medical Products has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has Utah Medical Products performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: UTMD has high quality earnings.
Growing Profit Margin: UTMD's current net profit margins (27.8%) are lower than last year (28.4%).
Past Earnings Growth Analysis
Earnings Trend: UTMD's earnings have grown by 1.1% per year over the past 5 years.
Accelerating Growth: UTMD's earnings growth over the past year (2.2%) exceeds its 5-year average (1.1% per year).
Earnings vs Industry: UTMD earnings growth over the past year (2.2%) underperformed the Medical Equipment industry 40.5%.
Return on Equity
High ROE: UTMD's Return on Equity (11.9%) is considered low.
How is Utah Medical Products's financial position?
Financial Position Analysis
Short Term Liabilities: UTMD's short term assets ($70.6M) exceed its short term liabilities ($4.4M).
Long Term Liabilities: UTMD's short term assets ($70.6M) exceed its long term liabilities ($5.0M).
Debt to Equity History and Analysis
Debt Level: UTMD is debt free.
Reducing Debt: UTMD had no debt 5 years ago.
Debt Coverage: UTMD has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: UTMD has no debt, therefore coverage of interest payments is not a concern.
What is Utah Medical Products's current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: UTMD's dividend (1.28%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.33%).
High Dividend: UTMD's dividend (1.28%) is low compared to the top 25% of dividend payers in the US market (3.6%).
Stability and Growth of Payments
Stable Dividend: UTMD's dividends per share have been stable in the past 10 years.
Growing Dividend: UTMD's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonably low payout ratio (32.2%), UTMD's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Kevin Cornwell (74 yo)
Mr. Kevin L. Cornwell has been the Chairman of the Board at Utah Medical Products Inc. since 1996 and its President and Chief Executive Officer since December 1992. Mr. Cornwell has been Secretary of Utah...
CEO Compensation Analysis
Compensation vs Market: Kevin's total compensation ($USD327.34K) is below average for companies of similar size in the US market ($USD1.67M).
Compensation vs Earnings: Kevin's compensation has been consistent with company performance over the past year.
Experienced Board: UTMD's board of directors are seasoned and experienced ( 24.2 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: UTMD insiders have only sold shares in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Utah Medical Products, Inc.'s employee growth, exchange listings and data sources
- Name: Utah Medical Products, Inc.
- Ticker: UTMD
- Exchange: NasdaqGS
- Founded: 1978
- Industry: Health Care Supplies
- Sector: Healthcare
- Market Cap: US$324.548m
- Shares outstanding: 3.65m
- Website: https://www.utahmed.com
Number of Employees
- Utah Medical Products, Inc.
- 7043 South 300 West
- United States
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/09/18 22:13|
|End of Day Share Price||2021/09/17 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.